Radioisotopic scanning of brain, liver, lungs and the skeleton is briefly reviewed with a survey of recent developments of clinical significance. In brain scanning neoplasm detection rates of greater than 90%O are claimed. The true figure is probably 70-80%. Autopsy data shows a number of false negatives, particularly with vascular lesions. Attempts to make scanning more specific in differentiating neoplasm from vascular lesions by rapid sequence blood flow studies are reviewed.
Introduction
This brief review is intended to look at some of the more common applications of radioisotope scanning, and also at certain new developments, in their clinical setting. Recent changes in detecting apparatus and in radiopharmaceuticals are widening the scope of scanning procedures, making investigations more specific; this outline may indicate the type of information and the order of accuracy that can be expected from the various investigations covered.
Brain scanning
Brain scanning is the most fruitful application of radioisotope scanning. It achieves this position partly from its accuracy and simplicity, partly because of the problems posed by other means of investigating the brain. It has been shown that the plain skull radiograph rarely provides new information when used as a screening test in, for instance, the detection of occult tumours in late onset epilepsy (Bull & Zirkha, 1968) . Angiography or pneumoencephalography, however, carry too high a morbidity to be undertaken lightly or without fairly definite indications. Brain scanning, therefore, which has few false positives, an accuracy of about 75 % for brain tumours, with no morbidity or mortality, performs a very good screening test in this situation.
The usefulness of brain scanning, however, is not limited to its role as a screening test. It can also be applied to the patient with a neurological deficit undergoing investigation and will often in these circumstances give added information additional to that provided by arteriography. Accurate localization of neoplasms, for example, prior to surgery may sometimes be more easily made on the scan than the angiogram, especially for mid-line tumours. Perhaps of greater help is the situation of a patient with multiple lesions, due for instance to metastatic deposits; a situation usually readily diagnosed on the brain scan but often less easily visible on the arteriogram.
The distinction between brain tumours and vascular lesions is often still impossible, but with recent advances in techniques the brain scan is becoming more and more specific. Some indication of cerebral blood flow can be obtained by sequential scanning and again, by rapid sequential pictures, an indication of the patency of major extra-cranial vessels can be obtained.
For a technique of such wide and proven usefulness there is marked under-utilization in this country. Calculation based on a DHSS report relating to 1970 shows that at that time about sixty brain scans were performed daily for the whole of England and Wales. In relation to the number of patients undergoing neurological investigations each day this seems a very small figure indeed.
Technique and radiopharmaceuticals
The concept of brain scanning and early techniques were pioneered by Moore (1948) who utilized a hand-held Geiger-Muller counter to detect iodinelabelled fluorescein and later, iodine-labelled human serum albumin. Mercury-labelled neohydrin was introduced by Bender in 1959 and in 1964 Harper et al., introduced 99m technetium. This agent, because of its convenience and favourable physical characteristics is now the most widely used agent. Chelates of ll3mindium are also in use, but offer no advantage over technetium. Coincident with these advances in radiopharmaceuticals there has been a vast improvement in apparatus for detection and display of radioactivity. This has taken the form of the evolving linear scanner, now usually with twin opposed heads which scan the patient and print out a static picture on film or paper. The alternative and probably more widely used instrument for brain scanning is a gamma camera; a single large detector which can be used either to build up a static picture or can record dynamic events such as the changing distribution of a bolus of radioactivity as it passes through a vascular bed. Tomographic cameras and scanners are now coming into use and the advantages of such instruments have been beautifully demonstrated by Kuhl & Sanders (1971) . Considerable efforts have gone into 'data processing' of scans, either in the form of the analysis of time activity curves or the recording and subsequent manipulation of static pictures. It seems doubtful at the time of writing whether these procedures add more than marginally to the accuracy of scanning, but for a review of this subject see Popham (1972) .
The normal brain scan Radiopharmaceuticals used for brain scanning are based on the fact that normal brain tissue is relatively impermeable, i.e. the radioactivity remains within the intravascular bed. Many lesions of the brain result in an increased permeability of this vascular bed resulting in a leakage of radio-activity into the lesion. As the radiopharmaceutical is excreted and blood cleared this area of leakage is increasingly apparent against the very low radioactivity of the surrounding brain. Large 'blood pools' such as venous sinuses are seen because of residual radioactivity and it is evident from this description that other abnormal blood pools such as aneurysms and arteriovenous malformations will also appear. It will also be apparent that the change in blood/brain barrier is non-specific. However, some indication of the pathology may be obtained as outlined in ensuing sections.
In performing a brain scan with technetium the patient should be premedicated by potassium perchlorate by mouth some 2 hr before the examination, to prevent uptake in thyroid, salivary glands, choroid plexus and gastro-intestinal mucosa. Normally 10 mCi 99mTc as pertechnetate is injected intravenously and at least four views (both laterals, a frontal and a posterior view obtained at 60 min, each view containing at least 200,000 scintillations. If a gamma camera is used, this can be supplemented by additional views, such as the vertex view and views of the posterior fossa. A further advantage of the use of the gamma camera is its use in recording 'dynamic' events. A series of rapid exposures using an automatic camera will record the passage of a bolus of radioactivity through the arterial and venous phases of the cerebral circulation. This method can be used to visualize the major extracranial vessels.
The normal brain scan (Fig. 1) shows a 'halo' of radioactivity due to the scalp and soft tissues, and superimposed on this the venous sinuses are visible. The tongue, paranasal sinuses and mucosa of the nasopharynx all show relatively high levels of radioactivity. The posterior fossa can normally be seen quite readily, but overlying soft tissues cause a higher count rate, which tend to obscure pathology.
Brain tumours
Apart from acoustic neuromas (Baum & Rothballer, 1972) , which appear to take up pertechnetate, most brain tumours show lower levels of activity when compared to blood. Normal brain, however, has a very low level of radioactivity and therefore a ratio between 10 and 20: 1 of tumour to brain can be achieved (Schwartz & Tator, 1972) . The diagnostic accuracy for supratentorial brain tumours is approximately 75 % (Bucy & Ciric, 1965; McAfee et al., 1964) , although in some series detection rates of 90 % are claimed (Kuba, Klaus & Sevcik, 1971 In the frontal views there is a halo of radioactivity due to the scalp and soft tissues, the saggital sinus lies in the mid line with symmetrical areas of low count rates over the cerebral hemispheres on both sides. The lateral and sigmoid sinuses are seen on the posterior and lateral views, the area below representing posterior fossa. Note the high level of radioactivity in the face and nasopharynx.
are obtained from necropsy data. Thus Krishnamurthy et al. (1972) examined data on eighty-four patients who had had a brain scan within 6 weeks of death. The total success rate was 66 % correct. There was only one false positive, but thirty-three patients had lesions shown at necropsy who had previously had a negative brain scan. The majority of these were vascular lesions, but five metastatic tumours and two primary tumours were missed, one an acoustic neuroma and one a 'Iymphosarcoma'.
Vascular lesions of the brain
As mentioned in the section on the normal brain scan, large aneurysms and arteriovenous malformations may be visible on the scan, especially using 'early' pictures, but these will not be considered further. Three other types of vascular lesions of the brain, namely brain infarcts including intracerebral haematomas, subdural haemotomas and major lesions ofthe extracranial vessels, can all be diagnosed with varying degrees of accuracy by brain scanning.
Infarction of the brain may cause an abnormal brain scan (Fig. 5) . The scan characteristically has poorly delineated margins fading off into the normal brain tissue and frequently covers a relatively large area of brain. The proportion of patients showing this abnormality on the scan varies in different series that have been followed (Morrison et al., 1965; Glasgow, Currier & Goodrich, 1967 
FIG. 2.
Brain scan in metastases from bronchial carcinoma. Brain scan on a 51-year-old man who presented with a monoparesis of his right leg of I week's duration. Chest X-ray showed a mass in the right upper lobe. The brain scan shows two areas of increased activity, one in the right frontoparietal region seen on the anterior and right lateral view (appearing more diffusely also on the left lateral) and a second lesion in the left posterior parietal region seen on the left lateral and posterior views. These lesions were confirmed at necropsy at which time other smaller metastases were also seen.
during the first 2-3 weeks (Molinari, Percher & Hayman, 1967 (Rosenthall, 1971 
ImS
La angiogram showing displacement of vessels due to large mass in left occipital region and also displacement of anterior cerebral artery by a subfronted mass (arrowed). At necropsy a glioma was found in the left posterior temporal area, and a subfrontal meningioma also shown. in ten patients and compared in accuracy with other techniques such as ophthalmodynamometry, and Dopler ultra-sound. They also showed one false positive out of twenty-one normals.
Turning to brain scanning applied to head trauma and the diagnosis of subdural or extradural hematomas it is doubtful if at the moment brain scanning has a vital role. The chronic subdural hematoma will produce a characteristic abnormality on the brain scan with a crescentic peripheral increase of activity often high up near the vertex. This appearance, however, may not be present during the first 24 or 48 hr of illness and moreover may be produced by soft tissue lesions overlying the skull vault. The brain scan, therefore, is of most use in patients suspected of chronic subdural hematoma (as opposed to acute head trauma). Arkles, Andrews & Steven (1972) reviewing twenty-three reported 'subdural hematomas', however, found proof of this diagnosis in only twelve; that is, there were eleven false positives. Vaughan et al. (1971) were successful in all of their small series, but I think the more general view is that the scan is not a reliable index of cerebral injury in acute head trauma and that the diagnosis of chronic subdural hematoma is liable to mis-interpretation due to rotation and other technical faults.
Brain scanning in inflammatory and other lesions
There is inadequate space to review the large number of conditions which may be associated with an abnormal brain scan. It should be pointed out, however, that abnormalities of both the soft tissue and skull vault as well as the underlying meninges may cause focal areas of increased activity and these should not be misinterpreted as representing a cerebral lesion (Tow & Wagner, 1967) . Most intracerebral abscesses give strongly positive brain scans (Jordon, James & Hodges, 1972) but there is evidence that the scan may not become positive for 1-2 weeks and may remain positive long after surgical evacuation (Overton, Haynie & Snodgrass, 1965) .
Both meningitis and encephalitis may be associated with often rather diffuse areas of increased activity (McLaughlin, Crocker & Morris, 1972; Cuzer & loannides, 1971) .
Liver scanning
Radioisotope scanning of the liver is perhaps the second most common organ scanning procedure. Like brain scanning it is a simple, cheap and atraumatic way of getting a picture of an organ which is difficult to investigate radiologically. However, as will become apparent, its accuracy is not as great as the brain scan. It is possible that further advances in radiopharmaceuticals may increase the accuracy of detection of various diseases in the future.
Radiopharmaceuticals
The usual way to visualize the liver depends on its ability to clear colloidal particles from the blood into the Kupffer cells. Various types of particle have been used, including radioactive colloidal gold (Stirrett, Yuhl & Cassen, 1954) , heat denatured human serum albumin (Benacerraf et al., 1957) and probably the most widely used agent, technetium-labelled sulphur colloid. 1l3mlndium-labelled ferrous hydroxide is also in use, but probably less widely than technetium. Such particulate matter, when injected intravenously is cleared by the whole of the reticuloendothelial system of which the liver forms only one part. Other organs which are visualized are, therefore, the spleen and bone marrow. Both the rate of clearance and the trapping of colloidal particles by different organs are influenced by particle size. The most commonly used agents show a distribution of 80% or more of radioactivity located in the liver, 10-15% in the spleen and approximately 500 in the bone marrow. Since the extraction ratio for any one preparation remains constant for normal livers the hepatic uptake of labelled colloidal particles can be used as a measure of hepatic blood flow (Shaldon et 1961). In the case of the abnormal liver, however, the significance of clearance rates of the blood and hepatic uptake are difficult to interpret since there may be alteration not only in hepatic blood flow but in extraction efficiency. An alternative radiopharmaceutical originally introduced by Taplin, Meredith & Kade (1965) is radio-iodinated Rose Bengal. This dye, introduced as a measure of hepatic function, is metabolized by hepatocytes and excreted in the bowel. Scans using this agent will therefore show both liver outline, visible at about 15 or 20 min and, in later scans, radioactivity can be seen in both the biliary tract and the small bowel. A further radiopharmaceutical occasionally applied to liver scanning is 75seleno-methionine. This labelled amino acid, commonly used for pancreatic scanning, is metabolized by hepatocytes, but also by certain neoplasms of the liver, principally hepatomas (see below).
The normnal liver scan
The typical appearance of a normal liver scan is illustrated in Fig. 7 . The outline of the liver is smooth with the exception of a notch adjacent to the gall bladder bed. Some diminution in activity between right and left lobes corresponds to the aorta and inferior vena cava, and also the porta hepatis. One of the problems of assessing liver scans is the variability in shape of an organ which is moulded by surrounding structures. The costal margin may produce an indentation on the lateral aspect which may be mistaken for liver replacement. The diaphragmatic surface of the liver shows considerable variation, and the over-lapping shapes of right and left lobes in the lateral view can cause difficulties of interpretation.
The liver size can be accurately assessed from the liver scan and calculations deriving liver volume from the scan correlate well with autopsy measurements (Rollo & Deland, 1968) .
Displacements of the liver by adjacent masses or collections of fluid may be shown and occasionally for this purpose simultaneous scanning of lungs and liver may be helpful. 
Focal liver replacement
The replacement of liver parenchyma by malignant growth, benign tumour or inflammatory tissue will result in the same appearance on the liver scan; a circumscribed 'cold' area (Fig. 8) . The accuracy with which lesions are detected depends on their size and position (Vidrih & Higgins, 1971 Ause & Wagner, 1965; Powell & Mangum, 1972) .
Our own experience applied to 75 patients with breast carcinoma has shown much poorer figures (Nathan, 1972) . In ten patients with proven deposits at necropsy or laparotomy the scan was abnormal in five and doubtful in a further two, but in all five positive scan patients the diagnosis was apparent clinically.
The application of liver scanning to suspected liver abscess can be very valuable. In most cases the lesion is clearly seen and the scan can be used to aid aspiration or surgical exploration and subsequent follow up (Fig. 9) .
Cirrhosis of the liver
Liver scanning using a colloid produces a fairly characteristic picture in cirrhosis of the liver. The liver is frequently small and shows an irregular distribution of radioactivity, trapping of colloid being reduced throughout. The spleen is usually enlarged and traps relatively more colloid and, unlike the normal scan, the spinal marrow is often clearly seen due to the relatively poor clearance of colloid by the liver.
One of the problems which presents in cirrhotic patients is the diagnosis of coincident hepatoma. Usually as stated above the liver shows diffuse irregularity of uptake of colloid but may at times show more focal defects, still due to cirrhosis. On the colloid scan this appearance may be indistinguishable from a hepatoma. Under these circumstances a repeat examination using 75seleno-methionine may be helpful. The hepatoma usually will metabolize the labelled methionine, whereas fibrous tissue or inflammatory lesions will appear as a cold area. If, therefore, the lesion seen on the colloid scan 'fills in' with selenomethionine then this indicates the likelihood of hepatoma (Eddleston et al., 1971) (Fig. 10) .
Lung scanning Radiopharmaceuticals and technique
The earliest investigations on the lung with radionuclides used radioactive gases. Knipping et al. (1955) studied pulmonary disease by using radioactive xenon with single counters over the chest. Such studies using radioactive xenon with single or multiple counters are still in use for physiological observations. West (1960) and Dollery & West (1960) used the short-lived isotopes of oxygen and carbon available from a cyclotron to make fundamental observa- tions on the physiology of pulmonary blood flow and gas exchange. Such work used either fixed detectors or scintillation counters which moved from top to the bottom of the lung to give numerical data. With the introduction of metabolized iodinated macroaggregates of human serum albumin by Taplin et al. (1964) and Wagner et al. (1964) Radioactive gases, mainly 133xenon, are now coming into wider use again, apart from their use by physiologists, due to the increasing potentialities of the gamma camera. Here the data processing system facilities coupled with the use of the gamma camera may give not only an organ scan but also numerical physiological data. The only gas widely available for this use, however, is 133xenon which has a rather low energy gamma radiation which limits its usefulness. 81mKrypton, which has a very short half-life (13 sec), is available from a cyclotron, but again is inconvenient for routine use. Such radioactive gases can be used to obtain a record of regional pulmonary blood flow when injected intravenously dissolved in saline, and the same gas can also be used for making assessments of ventilation and gas exchange (see below).
Ventilation studies can also be performed using a radioactive aerosol (Taplin & Poe, 1965) . Such an aerosol can be labelled using technetium and used in association with pictures performed by a gamma camera. Abnormal patterns due to chronic lung disease can be recorded and excess aerosol is seen in areas of narrowing or deformed parts of the bronchial tree.
The normal lung scan A typical preparation for performing a lung scan contains 5 mg of human serum albumin in the form of macroaggregates, ranging from 15 to 70 ;m in size, labelled with technetium. The macroaggregate is injected intravenously with the patient either lying or sitting. These two positions will, however, result in a different distribution of particles, since there is greater perfusion of lung bases when the patient is erect. The macroaggregate should be agitated before injection and should not be mixed with blood in the syringe. The appearance of the normal perfusion lung scan is illustrated in Fig. 11 . Both frontal and lateral views should be obtained. Points to note are that the margins of the lungs are smooth with relatively more radioactivity at the bases than the apex. The mediastinum appears as an area of low radioactivity. The heart is clearly outlined on the anterior scan and may also infringe on the antero-inferior margin of the left lateral view. The 
Lung with pulmonary embolic disease
The major application of lung scanning is in pulmonary embolic disease. This is a natural use of this technique in a clinical situation which is otherwise difficult to diagnose with any accuracy. It has been shown that up to 35 % of post-operative patients suffer from venous thromboses in the leg (Flanc, Kakkar & Clarke, 1968) . The number of patients who suffer from pulmonary embolic disease as a result of this is uncertain, but minor emboli are undoubtedly very common in hospital populations and recent emboli are found in between 20% and 5000 of necropsies (Freiman, Suzemoto & Wessler, 1965; Rywlin, 1970) . The chest X-ray is frequently non-contributory, but may show enlargement of one pulmonary artery or a relative area of avascularity and the position of the diaphragm may also change. In this situation the lung scan characteristically shows well demarcated, often segmiental, defects of perfusion (Fig. 12) . These are usually multiple, often causing 'bank-like' areas of decreased activity to appear on the scan. Where the chest X-ray shows clear lung fields, then one can usually ascribe these appearances to focal defects of perfusion due to pulmonary emboli. Where, however, an avascular area on the scan corresponds to an opacity seen on the chest X-ray the situation is more complex. Areas of collapse or pneumonia may show decreased pulmonary blood flow and therefore the scan of this lesion is not diagnostic. In most cases of pulmonary embolic disease, however, further avascular areas are present elsewhere due to the liberation of emboli which have not caused infarction, and this may .... The perfusion defects seen on the lung scan correlate well with those shown on pulmonary angiography (McIntyre & Sasahara, 1971) . Experience of using both techniques suggests that the lung scan is more sensitive, although obviously not so specific an investigation as the arteriogram. Defects will be seen on the scan where an examination of the arteriogram shows no obvious abnormality. This is readily understandable in view of the superimposition of relatively small vessels on the angiogram and the difficulty of identifying an occlusion of such small branches.
Lung scanning can be used to follow the natural history of pulmonary embolic disease (Fig. 12) . Sequential scans following acute pulmonary embolus frequently show changes occurring during the first few days, often with an altering pattern of perfusion defects and a resolution of some areas occurring fairly rapidly (Secker-Walker, Jackson & Goodwin, 1970) . A total recovery, however, to a normal pattern may take many months. Thus Tow & Wagner (1966) found that less than half of moderate sized perfusion defects following an acute pulmonary embolus had completely resolved at the end of 4 months.
Chronic lung disease
Since changes in ventilation will produce a concomitant change in perfusion many types of chronic lung disease will produce an abnormal lung scan. This situation is most dramatically illustrated in patients with bronchial asthma, where if lung scanning is carried out during an acute attack, focal areas of poor perfusion may be observed which return to normal again when the ventilation is restored and the bronchospasm is relieved. Lung scanning can be applied to bullous emphysema where the possibility of surgery is contemplated and a relative blood flow to the two lungs is recorded by the lung scan. Probably the most useful mode of investigation in these patients, is however, to look at both perfusion and ventilation (Fig. 13) . This can be done either separately or using 133xenon for ventilation studies followed by macroaggregates, or xenon can be injected intravenously during breath holding, thus giving a record of perfusion, since the gas is liberated FIG 13 b, c, d. group.bmj.com on October 19, 2017 -Published by http://pmj.bmj.com/ Downloaded from in the alveoli in proportion to their blood flow. The subsequent wash-out of this gas from the alveoli can be used as a measure of regional ventilation (Farmelant & Trainor, 1971; Medina et al., 1969) .
Lung scanning in other diseases
Lung scanning has been applied to cases of bronchogenic carcinoma in attempts to assess operability and/or progress, but it is doubtful if this application has a very useful place. Lung scanning has also been applied to pulmonary hypertension secondary to raised left atrial pressure, where the relative counts over the base and apex can be related to changes in blood flow induced by increases of left atrial pressure (Friedman & Braunwald, 1966) . A further applicationyf lung scanning is in the comparatively rare cases of pulmonary hypertension due to vascular changes in the pulmonary capillary bed. These may be either in the form of 'idiopathic' or primary pulmonary hypertension, or secondary to chronic thromboembolic disease. It can be shown that the distinction between these two groups can be readily made on the basis of the lung scan and this distinction correlates well with the results of arteriography (Wilson et al., 1973) .
Bone scanning
It has long been known that a number of radionuclides show bone localization, and work with 45calcium by Pecher in 1942 showed that this isotope had its highest concentration in areas of new bone formation. No suitable isotope of calcium is available for scanning, but a large number of other radionuclides have been explored. All depend on local increases in areas of high bone turnover where they exchange with portions of the hydroxy-apatite crystals. Local increases of radioactivity are seen in relation to fractures, osteomyelitis, primary tumours of bone, and most important in its clinical applications, in the neighbourhood of metastatic tumour deposits.
Radiopharmaceuticals
The obvious tracer to outline the skeleton and exchange with the calcium present in the hydroxyapatite crystals would be a radioactive calcium, but no suitable isotope exists with desirable physical characteristics. Strontium, however, has been shown to behave in a similar fashion to calcium in the body and two isotopes of strontium are in use for bone scanning. 85Strontium with the half-life of 65 days has the disadvantage of a delay of at least 48 hr between the moment of injection and the scan. Small amounts of this isotope are also excreted into the bowel. An advantage with the use of this isotope, however, is the fact that blood levels of radioactivity fall to a low point, thus allowing a clear visualization of the skeleton and any lesions. 87mStrontium with a half-life of 2-8 hr is available from a generator and allows scanning earlier after injection. 18Fluorine is a cyclotron produced radioisotope with a half-life of 2 hr. Due to the method of production and its short half-life this isotope is not generally available, but the quality of scans produced by 18fluorine is better than that when strontium is used (French & McCready, 1967; Galasko et al., 1968;  Ronai, Winchell & Anger, 1968) . In the last year or so a number of other agents have been suggested and assessed on an experimental basis. 67Gallium and 68gallium have been used as bone-seeking isotopes for a number of years (Dudley & Maddox, 1949) . Isotopes of barium and dysprosium have also been used for the same purpose (Spencer, Lange & Treves, 1971; Subramanian et al., 1971a) .
The most recent development in this field has been the exploration of various phosphate compounds which could be labelled with technetium.
Work by Subramanian & McAfee (1971) showed that complex of tripolyphosphate and stannous chloride could be labelled with technetium and produced clear images of the skeleton at 3 hr with considerably higher activity around new bone in callus.
Since then a number of agents based on phosphates have been investigated, including long chain polyphosphates (Subramanian et al., 1971b) and phosphonates (Yano et al., 1972) . At the moment it is still uncertain whether these agents differ greatly from each other. Clinical trials show excellent skeletal detail with individual ribs and vertebral bodies being clearly shown. There seems little doubt that using such agents bone scanning will be possible on a wider scale than at the moment.
Bone scanning for metastatic tumour As outlined the major application of bone scanning is in the detection of occult bony metastases. The mechanism behind the local increase in bone seeking agents in the region of bone tumours has been investigated by Charkes, Sklaroff & Young (1966) who found a close relationship between the presence of immature reactive bone formed in response to tumour cells and localized increased concentration of 85strontium. The appearance of an abnormal bone scan may precede radiological abnormalities. This has been shown by a number of workers. Thus Charkes, Sklaroff & Young (1966) found 21% of abnormal scans, in patients suffering from back pain and a cancer elsewhere, who had negative X-rays. Similar figures for positive scans with negative radiology have been noted by De Nardo (1966) , French & McCready (1967) and Galasko et al. (1968) . In a follow up of such cases the lesion will become apparent radiologically up to 18 months later.
If bone scanning is used as a screening procedure preceding surgery or the institution of systemic therapy, then the whole or major part of the skeleton must be seen. This requires some form of whole body scanning, or alternatively the gamma camera can be used either with a pin hole collimator or to take multiple views. Comparison of the various techniques has been reviewed by Krishnamurthy et al. (1972) and Merrick (1973) . Galasko (1969) carcinoma (Sauerbrunn et al., 1972) and also carcinoma of the prostate show a similar incidence of occult bone tumour discovered by bone scanning (Roy, et al., 1971) . The number of patients who show radiological bone lesions with negative bone scans is very small apart from those caused by benign lesions such as bone islands. Charkes, Sklaroff & Young (1966) suggest that in 5% of patients a scan of a radiolucent area is negative. They say that in the early phases of bone destruction with little in the way of reactive new bone the scan may be negative or minimally positive. Having gone through a phase of marked bone reaction it may then become a sclerotic lesion with again little in the way of bone turnover. The scan, having previously been markedly positive, then becomes either negative or shows a minimal localization. Experience using 18flUorine at the Hammersmith Hospital, however, shows that the incidence of negative scans with positive radiological findings is very low (Merrick, 1973 ). An illustration of a positive bone scan due to metastatic tumour is given in Fig. 14.
Scanning in other bone disorders Since a positive bone scan is associated with the presence of calcifying osteoid it follows that this includes a variety of bone lesions. It is for this reason important in bone scanning to make a strict comparison between radiological and scanning findings.
Primary tumours of bone may be delineated by bone scanning and this subject has been explored by Harmer et al. (1969) . These authors found that they were able to depict the extent of primary tumours of bone by using 18fluorine and that bone scanning could also indicate the recurrence of tumour following treatment with radiotherapy.
Paget's disease shows marked increased uptake of radioisotopes (Fig. 15) . Other primary diseases of bone such as fibrocystic disease and infective lesions of bone will also be shown on scanning. Hypertrophic pulmonary osteoarthropathy may also be identified on a bone scan (Chaudhuri, Schapiro & Christie, 1972) . Degenerative arthritis is associated with new bone formation and therefore will cause local increased activity of radionuclides (Fig. 16 ). This fact has been used to study changes in various types of arthritis (Muheim & Crutchlow, 1971) .
Bone scanning, or alternatively surface counting over bone, has been used in trying to assess union or non-union in fractures. Illingworth & Schiess (1971) found that strontium achieved maximum localization over fractures at 6-8 months. Examining fractures at 24 hr, however, using strontium as a bone localizing agent, was not useful in predicting the subsequent union or non-union of fractures of the tibia. Tritiated thymidine and 32P radioactive phosphorus are both incorporated in actively growing cell groups, but cannot be detected externally.
75Se-labelled methionine is also metabolized by cells and this factor has been utilized to detect lymphomas (Herrera et al., 1965) .
Matthews & Molinaro (1963) assayed a large number of different compounds in relation to their tumour localization and found that niobium, bismuth and iodinated human serum albumen all achieved relatively high tumour levels. lodinated human serum albumen has been widely used as a brain scanning agent, but also used to localize other tumours in man (Bonte, CurTy & Oelze, 1966) . Neither bismuth nor niobium has been used clinically.
Fibrinogen is known to be present in experimental tumours (Day, Planisek & Pressman, 1959) and this has been used for the localization of malignant tumours in man (Monasterio, 1964) .
The known property of fluorescence of tetracycline in malignant tumours has been explored (Eskelson et al., 1963) , and a labelled form of the synthetic vitamin K "Synkavit" has also been used both on experimental tumours and on a small group of patients (Marrian et al., 1969) . Radioactive mercury in the form of chlormerodrin was used by Sodee, Renner & Distefano (1965) on a variety of human new growths.
75Selenium, apart from its use as a label for methionine, has also been used as sodium selenite in the detection of tumours (Esteban et al., 1972) .
A specific tumour localizing agent for melanomas, a radioiodinated quinoline has been described by Bierwaltes et al. (1968) .
Of the compounds listed here, the three showing most promise have been mercury compounds, 75Se methionine and labelled fibrinogen. All these have shown about 70 % or more of known malignant masses. In the case of mercuric compounds and fibrinogen, localization has been shown in inflammatory masses.
67Galiium
One of the most interesting additions to this field is 67 gallium citrate. Edwards & Hayes, while using 67Ga as a bone scanning agent, noted increased localisation in malignant nodes in the neck, and in 1970 they reviewed forty-one patients, twenty-three of whom showed positive scans in neoplastic tissue.
Since then a number of papers have appeared reporting localization of gallium in malignant tissue (Winchell et al., 1970; Langhammer et al., 1972 ). Lavender et al. (1971 pointed out that 67gallium citrate also showed localization in inflammatory lesions, an observation since confirmed by others.
From the reports the total number of positive scans is 68%, but this success rate varies considerably with different tumours. Thus carcinoma of the lung can be shown in more than 90 % of patients (Fig. 17) but is liable to confusion with inflammatory lesions.
Lymphomas also show a fairly high success rate (Kay & McCready, 1972) but primary carcinoma of the breast and carcinoma of the stomach, for example, is less successful. 67Gallium has also been used to try to make liver scanning more specific. Lomas et al. (1972) report that in twenty-two patients from a group of twenty-seven with malignant involvement of the liver there was increased concentration of gallium compared to surrounding liver parenchyma (Fig. 18) .
The clinical applications of gallium therefore are uncertain. It undoubtedly indicates a high proportion of bronchogenic carcinomas but adds little new information. In lymphomas it may well have a real place in indicating mediastinal involvement, but in all applications there are two objections to its use: firstly the uneven and unpredictable distribution in any single patient, and secondly its liability to accumulate in inflammatory lesions and therefore produce false positive results.
"l Indium chloride and other recent tumour-seeking agents Because of the chemical affinities between gallium and indium, 'lindium which, like 67gallium has a fairly long half-life, has been put forward as a tumour localizing agent (Hunter & Riccobone, 1970; Goodwin, Goode & Brown, 1971) .
Our own experience using "lindium chloride on a small group of thirty patients with tumours showed poor success rate (Merrick et al., 1972) , only 22% showing positive scans.
A completely different principle in tumour localizing agents is the use of a labelled cytotoxic agent. Nouel et al. (1972) reported on the useof bleomycin, a cytotoxic agent derived from cultures of streptomyces, labelled with 57cobalt on ten patients with cancer, in all of whom positive scans were obtained. In two of these patients previously unidentified metastases were shown. Other reports on labelled bleomycin come from Japan Maeda, Kono & Kojima, 1972) .
Since 57cobalt is an unsuitable isotope for clinical use, an alternative labelling with "lindium has been tried both on experimental tumours and in a small group of patients suffering from neoplasms. The results as reported by Merrick et al. (1972) have been quite encouraging.
Conclusion
There is a tendency for the techniques of radioisotope scanning to lose credibility due to the rapidly changing techniques. This should not obscure the fact that well established procedures such as brain scanning are of considerable value to patient and clinician. The impending advances in bone scanning with the use of technetium-labelled compounds will, I think, rapidly expand the use of this procedure and make it available as a screening procedure of wide application.
Both liver scanning and lung scanning have a very real contribution in clinical management but must be read carefully in their clinical context. 'Tumour' scanning has always excited interest and recent advances seem to justify the efforts made. Even if such a technique is not wholly specific it may still be of value, either in showing the exact size of a known lesion or the total extent of disease. It looks as though this goal may be achieved.
